Document is current
Any future updates will be listed below
-
Authors
Moor, Matthias B. https://orcid.org/0000-0002-7717-651X
Dhayat, Nasser A.
Schietzel, Simeon
Grössl, Michael
Vogt, Bruno
Fuster, Daniel G.
-
Funding
Funding for this research was provided by:
schweizerischer nationalfonds zur förderung der wissenschaftlichen forschung (31003A_135503, 31003A_152829, 33IC30_166785/1)
swiss national centre of competence in research nccr kidney.ch
swiss national centre of competence in research nccr transcure
University of Bern
- License Information
-
More Information
Article History
Received: 14 July 2021
Accepted: 8 February 2022
First Online: 24 February 2022
Declarations
:
: DGF has served as a consultant for Otsuka Pharmaceuticals and Alnylam, and has received unrestricted research funding from Novartis, Abbvie, Otsuka Pharmaceuticals and Boehringer Ingelheim.
